Menu
GeneBe

COL5A1

collagen type V alpha 1 chain, the group of Collagens

Basic information

Region (hg38): 9:134641802-134844843

Links

ENSG00000130635NCBI:1289OMIM:120215HGNC:2209Uniprot:P20908AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Ehlers-Danlos syndrome, classic type (Strong), mode of inheritance: AD
  • Ehlers-Danlos syndrome, classic type (Strong), mode of inheritance: AD
  • Ehlers-Danlos syndrome, classic type (Definitive), mode of inheritance: AD
  • Ehlers-Danlos syndrome, classic type (Supportive), mode of inheritance: AD
  • arterial disorder (Limited), mode of inheritance: AD
  • Ehlers-Danlos syndrome, classic type, 1 (Strong), mode of inheritance: AD
  • Ehlers-Danlos syndrome, classic type (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Ehlers-Danlos syndrome, classic type, 1ADCardiovascular; ObstetricIndividuals with Ehlers-Danlos syndrome may have aortic root dilatation, but the natural history is unclear, and may not typically progress, though yearly surveillance with echocardiogram when aortic dilatation or mitral valve prolapse is peresent has been recommended; Precautions in pregnancy may be beneficial; Individuals with Fibromuscular dysplasia may have vascular complications, including aneurysms, and early diagnosis may provide early managementAudiologic/Otolaryngologic; Cardiovascular; Dermatologic; Musculoskeletal; Obstetric; Ophthalmologic8541855; 8923000; 9042913; 10602121; 10777716; 11992482; 12180144; 15264295; 15580559; 18972565; 20635400; 20847697; 20301422; 21611149; 22696272; 32938213
Homozygous variants have been reported

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the COL5A1 gene.

  • Ehlers-Danlos syndrome, classic type, 1 (2050 variants)
  • not provided (1221 variants)
  • Familial thoracic aortic aneurysm and aortic dissection (554 variants)
  • not specified (373 variants)
  • Ehlers-Danlos syndrome, classic type (197 variants)
  • Fibromuscular dysplasia, multifocal (185 variants)
  • Ehlers-Danlos syndrome type 7A (172 variants)
  • Ehlers-Danlos syndrome (124 variants)
  • Ehlers-Danlos syndrome, classic type, 1;Fibromuscular dysplasia, multifocal (45 variants)
  • Connective tissue disorder (37 variants)
  • COL5A1-related condition (18 variants)
  • Ehlers-Danlos syndrome, classic type, 2 (11 variants)
  • Fibromuscular dysplasia, multifocal;Ehlers-Danlos syndrome, classic type, 1 (8 variants)
  • Inborn genetic diseases (6 variants)
  • See cases (4 variants)
  • Ehlers-Danlos syndrome, classic type, 2;Ehlers-Danlos syndrome, classic type, 1 (3 variants)
  • Marfan syndrome (2 variants)
  • Abnormal bleeding (2 variants)
  • 6 conditions (2 variants)
  • Ehlers-Danlos syndrome, classic type, 1;Ehlers-Danlos syndrome, classic type (1 variants)
  • Familial thoracic aortic aneurysm and aortic dissection;Aortic valve disease 1 (1 variants)
  • Ehlers-Danlos syndrome, classic type;Ehlers-Danlos syndrome, classic type, 2 (1 variants)
  • Confusion (1 variants)
  • Dural ectasia;Venous malformation;Abnormal digit morphology;Hypertelorism (1 variants)
  • Abnormal bleeding;Thrombocytopenia (1 variants)
  • Stroke disorder (1 variants)
  • 10 conditions (1 variants)
  • Brugada syndrome (1 variants)
  • 13 conditions (1 variants)
  • Aortic root aneurysm (1 variants)
  • Loeys-Dietz syndrome (1 variants)
  • Hyperextensible skin;Cigarette-paper scars;Atrophic scars;Large joint dislocations;Joint hypermobility (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the COL5A1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
20
clinvar
475
clinvar
24
clinvar
519
missense
6
clinvar
20
clinvar
610
clinvar
75
clinvar
66
clinvar
777
nonsense
44
clinvar
10
clinvar
54
start loss
3
clinvar
3
frameshift
99
clinvar
19
clinvar
3
clinvar
121
inframe indel
3
clinvar
2
clinvar
24
clinvar
29
splice donor/acceptor (+/-2bp)
9
clinvar
36
clinvar
1
clinvar
46
splice region
4
2
86
108
5
205
non coding
1
clinvar
2
clinvar
58
clinvar
535
clinvar
310
clinvar
906
Total 165 89 715 1086 400

Highest pathogenic variant AF is 0.00000712

Variants in COL5A1

This is a list of pathogenic ClinVar variants found in the COL5A1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
9-134641806-C-G Ehlers-Danlos syndrome type 7A • Ehlers-Danlos syndrome, classic type • Ehlers-Danlos syndrome, classic type, 1 • Fibromuscular dysplasia, multifocal Benign/Likely benign (Mar 15, 2022)365696
9-134641824-G-C Ehlers-Danlos syndrome type 7A • Ehlers-Danlos syndrome, classic type, 1;Fibromuscular dysplasia, multifocal Uncertain significance (Feb 18, 2022)365697
9-134641831-G-T Ehlers-Danlos syndrome type 7A Uncertain significance (Jun 14, 2016)365698
9-134641901-G-C Ehlers-Danlos syndrome type 7A Uncertain significance (Jun 14, 2016)365699
9-134641909-T-TGGA Ehlers-Danlos syndrome type 7A Uncertain significance (Jun 14, 2016)365700
9-134641939-G-A Likely benign (Sep 20, 2019)1199542
9-134641941-T-G Ehlers-Danlos syndrome type 7A • Ehlers-Danlos syndrome, classic type, 1 • Fibromuscular dysplasia, multifocal Benign (Mar 15, 2022)365701
9-134641989-C-T Ehlers-Danlos syndrome, classic type Benign (Jan 13, 2018)915167
9-134642008-C-A Likely benign (Jun 26, 2018)1200990
9-134642049-G-T Ehlers-Danlos syndrome type 7A Uncertain significance (Jun 14, 2016)365702
9-134642078-A-G Ehlers-Danlos syndrome type 7A • Ehlers-Danlos syndrome, classic type • Ehlers-Danlos syndrome, classic type, 1 • Fibromuscular dysplasia, multifocal Benign/Likely benign (Mar 15, 2022)365703
9-134642151-G-A not specified • Ehlers-Danlos syndrome type 7A • Ehlers-Danlos syndrome, classic type • Ehlers-Danlos syndrome, classic type, 1 • Fibromuscular dysplasia, multifocal Benign/Likely benign (Nov 11, 2023)136921
9-134642152-AGCGCCCCTGTGCGCCCCGGCCC-A not specified Likely benign (Sep 12, 2017)512002
9-134642155-G-T not specified Likely benign (Aug 04, 2016)388399
9-134642171-G-A not specified Likely benign (Feb 09, 2017)507366
9-134642173-C-A not specified Benign (Oct 29, 2023)136923
9-134642174-C-T not specified Likely benign (Aug 01, 2017)511164
9-134642184-C-G Ehlers-Danlos syndrome, classic type • Fibromuscular dysplasia, multifocal • Ehlers-Danlos syndrome, classic type, 1 • Familial thoracic aortic aneurysm and aortic dissection Benign/Likely benign (May 30, 2023)506690
9-134642187-C-A Familial thoracic aortic aneurysm and aortic dissection Uncertain significance (Dec 14, 2022)2448282
9-134642188-A-G Ehlers-Danlos syndrome, classic type, 1 Pathogenic (Oct 14, 2021)1381199
9-134642189-T-G Ehlers-Danlos syndrome, classic type, 1 Pathogenic (Nov 26, 2022)2011378
9-134642190-G-T Ehlers-Danlos syndrome, classic type, 1 Pathogenic (May 30, 2023)2750255
9-134642193-C-G Uncertain significance (Oct 04, 2017)423543
9-134642194-G-T Ehlers-Danlos syndrome, classic type, 1 Uncertain significance (Mar 28, 2022)1478538
9-134642196-C-A not specified Likely benign (Nov 13, 2017)513316

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
COL5A1protein_codingprotein_codingENST00000371817 66203067
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.001.15e-17125729031257320.0000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.079371.13e+30.8270.000074711580
Missense in Polyphen245290.030.844732969
Synonymous-1.825264761.110.00003873909
Loss of Function9.7521150.01740.000005781322

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002890.0000289
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001760.0000176
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Type V collagen is a member of group I collagen (fibrillar forming collagen). It is a minor connective tissue component of nearly ubiquitous distribution. Type V collagen binds to DNA, heparan sulfate, thrombospondin, heparin, and insulin.;
Disease
DISEASE: Ehlers-Danlos syndrome, classic type, 1 (EDSCL1) [MIM:130000]: A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. The main features of classic Ehlers-Danlos syndrome are joint hypermobility and dislocation, and fragile, bruisable skin. EDSCL1 inheritance is autosomal dominant. {ECO:0000269|PubMed:10602121, ECO:0000269|PubMed:11992482, ECO:0000269|PubMed:15580559, ECO:0000269|PubMed:18972565, ECO:0000269|PubMed:9042913}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Protein digestion and absorption - Homo sapiens (human);Allograft Rejection;miRNA targets in ECM and membrane receptors;Focal Adhesion;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;miR-509-3p alteration of YAP1-ECM axis;Collagen chain trimerization;Collagen biosynthesis and modifying enzymes;Collagen formation;Extracellular matrix organization;Integrin;Validated transcriptional targets of deltaNp63 isoforms;Beta1 integrin cell surface interactions;Syndecan-1-mediated signaling events;Integrins in angiogenesis (Consensus)

Intolerance Scores

loftool
0.0114
rvis_EVS
-3.01
rvis_percentile_EVS
0.52

Haploinsufficiency Scores

pHI
0.693
hipred
Y
hipred_score
0.853
ghis
0.595

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.817

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Col5a1
Phenotype
integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); embryo phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype;

Gene ontology

Biological process
blood vessel development;heart morphogenesis;cell adhesion;cell migration;extracellular matrix organization;collagen fibril organization;collagen biosynthetic process;wound healing, spreading of epidermal cells;tendon development;skin development;integrin biosynthetic process;eye morphogenesis;regulation of cellular component organization;supramolecular fiber organization;negative regulation of endodermal cell differentiation
Cellular component
extracellular region;collagen type V trimer;basement membrane;extracellular space;endoplasmic reticulum lumen;extracellular matrix;collagen-containing extracellular matrix
Molecular function
integrin binding;extracellular matrix structural constituent;protein binding;heparin binding;extracellular matrix structural constituent conferring tensile strength;proteoglycan binding;metal ion binding;platelet-derived growth factor binding